Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 30, 2018 - Issue 3
6,491
Views
2
CrossRef citations to date
0
Altmetric
Review Article

Critical review of long-term ozone exposure and asthma development

, , , &
Pages 99-113 | Received 28 Dec 2017, Accepted 19 Mar 2018, Published online: 05 Jun 2018

Abstract

Asthma, a chronic respiratory disorder with complex etiology and various phenotypes, is a considerable public health concern in the USA and worldwide. While there is evidence suggesting ambient ozone exposure may exacerbate asthma, information regarding the potential role of ozone in asthma development is more limited. Thus, we conducted a critical review of observational epidemiology studies to determine whether long-term ambient ozone exposure is a risk factor for asthma development. We identified 14 relevant studies; 11 evaluated asthma development in children, while three studies, based on a single cohort, assessed this outcome in adults. Studies of childhood asthma and long-term ozone exposure – including exposure in utero, during the first year of life and during early childhood – reported inconsistent findings, which were further weakened by critical methodological limitations in statistical analyses and in exposure and outcome assessments, such as exposure measurement error and a lack of adjustment for key confounders. For adult-onset asthma, long-term ozone exposure was associated with an increased risk in men but not women. In addition to considerable uncertainties due to potential exposure measurement error and a lack of adjustment for key confounders, this study has limited generalizability to the US general population. While experimental evidence indicates that it may be biologically plausible that long-term ozone exposure could contribute to asthma development, it does not provide insight regarding an established mode of action. Future research is needed to address the uncertainties regarding the role of long-term ambient ozone exposure in asthma development.

Introduction

Asthma is a common chronic disease and a considerable public health concern in the USA, with an estimated prevalence of 7.7% in adults and 9.5% in children between 2008 and 2010 (Moorman et al., Citation2012). Globally, the prevalence of asthma is increasing in many countries, particularly among children (GINA, Citation2017). Asthma is a multifactorial, heterogeneous disease with many clinical phenotypes, each of which involves chronic airway inflammation, reversible airway obstruction and airway hyperresponsiveness (AHR) to various triggers, as well as airway remodeling in later stages of the disease (Bates et al., Citation2009; Currie & Baker, Citation2012; Grainge & Davies, Citation2013; Myers & Tomasio, Citation2011; Noutsios & Floros, Citation2014; Shin et al., Citation2009).

The etiology of asthma is complex, and a specific cause has yet to be identified. For childhood asthma, genetics (e.g. parental asthma), respiratory infections, prenatal exposure to environmental tobacco smoke (ETS) and premature birth are well-established risk factors (Bates et al., Citation2009; Myers & Tomasio, Citation2011; Noutsios & Floros, Citation2014; Subbarao et al., Citation2009); other putative risk factors include allergens, traffic-related air pollution, breastfeeding, family size, and structure and sex (Subbarao et al., Citation2009). In contrast, the risk of true adult-onset asthma (i.e. not a relapse of childhood asthma in adulthood) may be increased by allergic conditions, obesity, family history of asthma, and exposures to environmental allergens and irritants (Ilmarinen et al., Citation2015; Subbarao et al., Citation2009).

Many observational and experimental studies have investigated the potential association between short-term exposure to ozone and outcomes related to asthma severity, such as emergency department visits and hospital admissions for asthma, as well as respiratory symptoms and lung function changes in asthmatics (reviewed by Goodman et al., Citation2018). The evidence from these studies is suggestive of an association between short-term exposure to ambient concentrations of ozone and asthma severity (Goodman et al., Citation2018). By contrast, the potential impact of long-term ozone exposure on the development of asthma is unclear. The 2013 Integrated Science Assessment for Ozone and Related Photochemical Oxidants (ISA; US EPA, Citation2013a) reviewed observational epidemiology studies published through 2011 and concluded that the evidence supported long-term ozone exposure as a risk factor for asthma development in adults and as an effect modifier in children. Here, we conduct a critical review that includes more recently published observational studies that evaluated the association between long-term ambient ozone exposure and incident asthma.

Methods

Literature search and study selection

We searched PubMed and Scopus for studies published through October 2017 that evaluated long-term ozone exposure and asthma development using the following terms: (“ozone” OR “air pollution”) AND (“asthma development” OR “development of asthma” OR “asthma onset” OR “onset of asthma” OR “newly onset of asthma” OR “incidental asthma” OR “incidence of asthma” OR “asthma incidence” OR “airway hyperresponsiveness” OR “bronchial hyperresponsiveness” OR “wheeze” OR “wheezing”) AND (“prospective” OR “cohort” OR “longitudinal” OR “epidemiology” OR “epidemiologic” OR “epidemiological” OR “risk factor” OR “risk factors”). In addition, we cross-referenced the ozone ISA (US EPA, Citation2013a) and the bibliographies of review articles to identify any studies that were not found in the literature searches.

We included peer-reviewed observational studies of humans that evaluated the associations between long-term ozone exposure (defined as approximately 30 d or longer in duration; US EPA, Citation2013a) and incident asthma (i.e. incidence, incidence rate or lifetime prevalence of asthma). We excluded studies that met any of our exclusion criteria: laboratory animal or in vitro studies; experimental studies; reviews; editorials; commentaries; correspondence/communications; letters to the editor; studies that were not published in English; studies that did not evaluate long-term exposure to ambient ozone (e.g. studies that evaluated short-term exposure or indoor exposure); studies that did not evaluate incident asthma (e.g. studies that evaluated prevalence of asthma or asthma exacerbation); and studies that did not report specific results on the associations between long-term ozone exposure and incident asthma.

Data extraction

From each selected study, we extracted and tabulated information on general and quality characteristics, such as study design, location, study population/cohort, study period, sample size, various features of the exposure assessment (e.g. metric, averaging time, estimation method), outcome ascertainment and statistical approach (e.g. regression model, confounders adjusted for, sensitivity analyses). We also extracted and tabulated detailed study results and graphically presented the study-specific results with the risk estimates standardized to a 1 part per billion (ppb) increment in ozone concentrations.

Study quality evaluation

We developed detailed study quality criteria to evaluate the internal validity of selected studies. These criteria were tailored specifically for long-term ozone exposure and asthma development, and were based on several frameworks, including the Integrated Risk Information System (IRIS) Risk of Bias (RoB) evaluation (US EPA, Citation2013b, Citation2014), the National Toxicology Program’s (NTP) Office of Health Assessment and Translation (OHAT) approach (NTP, Citation2015a,Citationb), the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) system (von Elm et al., Citation2007a–e), the Navigation Guide (Koustas et al., Citation2013, Citation2014) and the recent ISAs for oxides of nitrogen (NOx) and sulfur oxides (SOx) (US EPA, Citation2016a,Citationb). We did not conduct a quantitative RoB evaluation (e.g. by categorizing studies into different quality tiers like in the OHAT approach) because it was extremely difficult, if not impossible, to delineate the magnitude and direction of the biases in the available observational studies. We also considered the external validity of the studies in relation to the US general population.

The quality criteria include various methodological attributes, which we applied to individual studies to assess their quality and risk of bias. We first considered the study design: cohort or nested case-control studies had a lower risk of selection bias than case-control studies.

Next, we considered various aspects of the exposure assessment, including spatial and temporal variability, residential mobility, exposure validation, and temporality between exposure and outcome. Studies that employed inverse distance weighting (IDW) or modeling of monitoring data better accounted for spatial variability of the ozone exposure than the studies that only relied on monitoring data. Studies that used time-varying ozone exposure estimates or assessed multiple exposure windows in their analyses better accounted for temporal variability than the studies that only used time-invariant ozone exposure and assessed a single exposure window. Studies that considered residential mobility in the exposure estimates or validated the exposure estimates likely had less exposure measurement error than studies that did neither. Also, studies that clearly established the exposure-outcome temporality (i.e. the exposure occurred before the outcome) had a lower risk of bias than the studies that did not.

We considered two aspects of assessing asthma development: the diagnostic accuracy in the study population and the ascertainment of asthma diagnosis. Because it is difficult to accurately diagnose asthma in small children (e.g. younger than 6 years of age; ATS, Citation2007; GINA, Citation2017), studies with participants aged 6 years or older had less potential for outcome misclassification than studies that included younger children. Studies that relied on medical records, hospital discharge records, insurance claims, or adults’ reports of physician diagnoses had less potential for outcome misclassification than the studies that used first asthma hospitalization as the surrogate for incident asthma. Asthma hospitalization, a serious exacerbation event, is a poor surrogate for incident asthma because only a small proportion of individuals with asthma are hospitalized (Akinbami et al., Citation2012). Also, ozone exposure may be associated with asthma severity (Goodman et al., Citation2018; US EPA, Citation2013a); therefore, the use of first asthma hospitalization, a severe exacerbation event, may bias the results regarding ozone and asthma development.

We also considered the robustness of the statistical analyses in each study. Studies that employed at least one of the following measures likely yielded more robust results than the studies that did not: used appropriate statistical models (e.g. logistical regression models for incidence/lifetime prevalence, Cox regression models for incidence rate) with the model assumptions tested (e.g. the proportional hazard assumption for Cox regression models); adjusted for potential confounders identified from the literature including age, sex, race, socioeconomic status (e.g. income, education attainment), maternal age, gestational duration, family history of asthma or allergy, smoking, indoor environment (e.g. mold, dampness, pet ownership), traffic-related pollution (e.g. NO2, PM2.5, distance to major roadway) and other environmental covariates (e.g. surrounding greenness); evaluated non-linear dose-response relationships (e.g. quantiles, splines); and conducted sensitivity analyses.

Last, we evaluated the external validity of the study relative to the US general population. We determined that the results of childhood asthma from western populations (i.e. North American and European cohorts) are more generalizable to the USA, while results from Asian children populations are less so. For studies of adult-onset asthma, if the characteristics of the study population were similar to those of the US general population, we concluded that the findings are generalizable to the USA.

Results

Literature search and study selection

The literature searches resulted in a total of 1279 publications, and we identified 28 potentially relevant epidemiology studies by reviewing titles and abstracts. We did not identify any additional publications from cross-referencing the ozone ISA and review articles. After full-text review, we excluded 14 studies, resulting in 14 studies for review ().

Figure 1. Selection of epidemiology studies for long-term ozone exposure and asthma development.

Figure 1. Selection of epidemiology studies for long-term ozone exposure and asthma development.

presents the general characteristics of the selected studies. The majority of the studies were conducted in the USA and Canada in the past two decades. Out of the 14 studies, 11 evaluated asthma development in children, while three studies based on a single cohort, assessed this outcome in adults.

Table 1. General characteristics of epidemiology studies of long-term ozone exposure and asthma development.

Study quality evaluation

We evaluated the internal and external validity of individual studies based on criteria we developed (). Thirteen out of the fourteen studies selected were cohort studies or nested case-control studies, which had a lower risk of selection bias than the one population-based case control study (Nishimura et al., Citation2013).

Table 2. Quality and generalizability of epidemiology studies of long-term ozone exposure and asthma development.

Regarding exposure assessment, there were considerable uncertainties in all of the selected studies. Several studies did not account for spatial variability or residential mobility when estimating ozone exposures. The majority of the studies did not account for the temporal variability in ozone exposure or validate the ozone exposure estimates. In addition, a source of considerable uncertainty in most of the studies with retrospective exposure assessment was a lack of temporality between the ozone exposure and the development of asthma (i.e. exposure windows covered time periods after the development of asthma).

Most studies of childhood asthma included children younger than 6 years old, in whom asthma could not be diagnosed accurately. However, these studies relied on medical records, insurance claims and parental reports of physician diagnoses to ascertain a diagnosis of asthma, which reduced the potential for outcome misclassification. Notably, Lin et al. (Citation2008) relied solely on hospital discharge records to identify a child’s first hospitalization for asthma as a surrogate for incident asthma, which, as discussed, is a poor proxy for asthma development. All of the studies of asthma development in adults ascertained incident asthma through self-reported physician diagnosis and symptoms, and thus had a low risk for outcome misclassification.

With regard to statistical analyses, most studies employed suitable statistical models and tested model assumptions when appropriate, except for those conducted by McConnell et al. (Citation2010) and Islam et al. (Citation2008), who did not test the proportional hazard assumption. Half of the 14 studies assessed potentially non-linear dose-response relationships by using quantiles or splines of ozone exposure in their analyses, and most conducted some form of sensitivity analysis. We also found that, while the vast majority of the 14 studies adjusted for confounders, such as age, sex, socioeconomic status and smoking, several studies did not account for race, maternal age, gestational duration, or family history of asthma or allergy, and few studies considered the potential confounding effects of indoor environment, traffic-related pollution or other environmental factors (e.g. surrounding greenness).

Regarding external validity, the majority of the studies were conducted in the USA, Canada and Europe, so their findings are more generalizable to the US population, compared to the three studies in Asia (Dong et al., Citation2013; Kim et al., Citation2013; Wang et al., Citation2016).

Overall, while findings from most of the selected studies are generalizable to the US population, limitations of ozone exposure assessment and the lack of adjustment for several key environmental confounders may impact the interpretation of study results.

Study results evaluation

We identified 11 studies from 10 non-overlapping populations that evaluated childhood asthma development, and three studies from one cohort that assessed asthma development in adults. As discussed above, all of these studies had considerable uncertainties and potential for bias with regard to exposure and outcome assessments and confounder adjustment. In light of the major methodological limitations in these studies, although several studies conducted some form of sensitivity analysis, we mainly focused on the study findings from the primary and stratified analyses with a focus on the within- and between-study consistency. Detailed study results are presented in .

Table 3. Detailed results of epidemiology studies of long-term ozone exposure and asthma development.

Childhood asthma

To aid the evaluation of study results regarding long-term ozone exposure and childhood asthma development, we graphically present the main findings from these studies in , with the risk estimates standardized to a 1 ppb increment in ozone exposure and grouped by exposure window.

Figure 2. Study-specific results of long-term ozone exposure and childhood asthma development, by exposure window – the relative risks and their 95% confidence intervals have been standardized to a 1 ppb increment in ozone exposure.

Figure 2. Study-specific results of long-term ozone exposure and childhood asthma development, by exposure window – the relative risks and their 95% confidence intervals have been standardized to a 1 ppb increment in ozone exposure.
Ozone exposure in utero

Two studies, both of which were birth cohorts in Canada, evaluated the association between in utero ozone exposure and childhood asthma (Clark et al., Citation2010; Sbihi et al., Citation2016). Sbihi et al. (Citation2016) reported that higher in utero ozone exposure was statistically significantly associated with decreased incident asthma in preschool-age children (OR = 0.92, 95% CI: 0.87–0.97). When ozone exposure was assessed as quartiles, the top three quartiles were all associated with reduced asthma risks (quartile 2: OR = 0.88, 95% CI: 0.81–0.95; quartile 3: OR = 0.95, 95% CI: 0.87–1.03; quartile 4: OR = 0.85, 95% CI: 0.77–0.94), compared to the bottom quartile. This statistically significant inverse association persisted among children with a gestational age of 37 weeks or longer (OR = 0.91, 95% CI: 0.86–0.96) or with a birth weight of 2500 g or more (OR = 0.9, 95% CI: 0.86–0.95) but was null for children with a gestational age less than 37 weeks or with a birth weight less than 2500 g. Clark et al. (Citation2010), who assessed incident asthma only in children aged younger than 5 years, also reported a statistically significant decrease in asthma development in association with increases in in utero ozone exposure (OR = 0.83, 95% CI: 0.77–0.89). The observed statistically significant inverse association persisted when the study population was stratified by sex (boys: OR = 0.86, 95% CI: 0.78–0.94; girls: OR = 0.79, 95% CI: 0.70–0.89).

In contrast, Sbihi et al. (Citation2016) found that higher in utero ozone exposure was associated with a statistically significant increase in incident asthma in school-age children (OR = 1.18, 95% CI: 1.07–1.31). The analyses with quartiles of ozone exposure showed that the risk of asthma was only increased in the top two quartiles, compared to the bottom quartile (quartile 2: OR = 1.02, 95% CI: 0.87–1.20; quartile 3: OR = 1.19, 95% CI: 1.01–1.41; quartile 4: OR = 1.22, 95% CI: 1.01–1.48).

Ozone exposure in the first year of life

Two studies assessed the association between ozone exposure in the first year of life and childhood asthma (Clark et al., Citation2010; MacIntyre et al., Citation2014). MacIntyre et al. (Citation2014), who conducted a pooled analysis of four birth cohorts in Canada and Europe, reported a null association between ozone exposure in the first year of life and the risk of ever being diagnosed with asthma up to 8 years of age. MacIntyre et al. (Citation2014) also evaluated the potential effect modification by several single-nucleotide polymorphisms (SNPs) in the glutathione S-transferase P1 (GSTP1) and tumor necrosis factor (TNF) genes and found that the null associations between ozone exposure and asthma did not vary by any of the SNPs examined. Similar to in utero ozone exposure, Clark et al. (Citation2010) observed a statistically significant inverse association between ozone exposure in the first year of life and incident asthma (full cohort: OR = 0.81, 95% CI: 0.74–0.87; boys: OR = 0.84, 95% CI: 0.76–0.94; girls: OR = 0.74, 95% CI: 0.64–0.84).

Ozone exposure in early life

Eight studies investigated the relationship between ozone exposure in early life and risk of developing asthma, and there is considerable between-study heterogeneity in the direction of observed associations.

Four studies, from three non-overlapping populations in the US and Korea, observed a null association between long-term ozone exposure in early life and risk of developing childhood asthma (Islam et al., Citation2008; Kim et al., Citation2013; McConnell et al., Citation2010; Nishimura et al., Citation2013), and the null associations did not vary by sex, family history of asthma, total IgE level, functional polymorphisms tested, the metric and averaging time of ozone exposure or measures of asthma development (Islam et al., Citation2008; Kim et al., Citation2013; Nishimura et al., Citation2013).

Conversely, Wang et al. (Citation2016), a retrospective cohort study in Taipei, reported a statistically significant decrease in risk of asthma associated with higher ozone exposure based on hourly measurements (OR = 0.68, 95% CI: 0.51–0.92). The association was no longer statistically significant when the 8 h mean ozone concentrations were used (OR = 0.79, 95% CI: 0.59, 1.07).

In addition, three studies reported statistically significant positive associations between the risk of childhood asthma and ozone exposure. Tetreault et al. (Citation2016), in a birth cohort study in Canada, found that higher ozone exposure during summer months in early life was associated with increased risk of developing childhood asthma (HR = 1.07, 95% CI: 1.06–1.08). Tetreault et al. (Citation2016) also evaluated the dose-response relationship using cubic splines of continuous ozone exposure but did not find any evidence for non-linearity. Dong et al. (Citation2013), who conducted a population-based cohort study in China, observed statistically significant increases in asthma development risk associated with increases in ozone exposure, and this positive association was not modified by body weight (normal weight: OR = 1.25, 95% CI: 1.12–1.40; overweight: OR = 1.53, 95% CI: 1.26–1.86; obese: OR = 1.31, 95% CI: 1.08–1.58). Lin et al. (Citation2008), in a cohort study in New York State, reported that higher ozone exposure in early life was associated with a statistically significantly increased risk of asthma hospitalization (OR = 1.16, 95% CI: 1.15–1.17). The results were consistent when only exposure in ozone season (April–October) was considered (OR = 1.22, 95% CI: 1.21–1.23) or when the annual percentage of hourly ozone measurements exceeding 70 ppb was considered (OR = 1.68, 95% CI: 1.64, 1.73). These increases persisted in the top two tertiles of ozone exposure when the study population was stratified by location (New York City: tertile 2: OR = 1.43, 95% CI: 1.29–1.58; tertile 3: OR = 1.69, 95% CI: 1.52–1.80 versus other New York State cities: tertile 2: OR = 1.64, 95% CI: 1.48–1.82; tertile 3: OR = 2.06, 95% CI: 1.87–2.27).

Adult-onset asthma

Three studies, all based on the Seventh-day Adventists (SDA) Cohort in California, assessed the risk of developing adult-onset asthma in association with long-term ozone exposure (Abbey et al., Citation1991; Greer et al., Citation1993; McDonnell et al., Citation1999).

For 6058 Seventh-day Adventists with a follow-up of 10 years, Abbey et al. (Citation1991) reported that higher ozone exceedance frequency (i.e. annual average of greater than 500 hourly ozone measurements above 100 ppb) was associated with a borderline significant increase in asthma risk (OR = 1.40, 95% CI: 0.90–2.34). Greer et al. (Citation1993) restricted their analyses to 3577 nonsmokers, and also reported a borderline significant increase in asthma risk associated with a 10 ppb increment in ozone exposure (OR = 1.31, 95% CI: 0.96–1.78). The positive association between ozone and asthma was more pronounced in men (OR = 3.12, 95% CI: 1.61–5.85) but was null in women (OR = 0.94, 95% CI: 0.65–1.34). McDonnell et al. (Citation1999), who analyzed 2758 nonsmokers with a follow-up of 15 years, also reported a statistically significant association between 20-year cumulative ozone exposure (based on daily 8 h mean concentrations) and asthma in men (OR = 2.09, 95% CI: 1.03–4.16) but a null association in women (OR = 0.86, 95% CI: 0.58–1.26). The results did not change meaningfully when daily hourly ozone measurements were used to calculate the 20-year cumulative ozone exposure. In addition, McDonnell et al. (Citation1999) assessed ozone exceedance frequencies above various thresholds and found that higher exceedance frequencies above 60 ppb were associated with statistically significant increases in asthma risk among men (OR = 1.90, 95% CI: 0.99–3.64) and that the statistical significance did not persist with higher ozone thresholds (e.g. 80, 100, 120 and 150 ppb). Ozone exceedance frequencies were not associated with asthma risk in women. When tertiles of ozone exposure were considered, men in the top two tertiles had a statistically significantly increased risk of asthma, compared to men in the bottom tertile (tertile 2: OR = 4.44, 95% CI: 1.32–13.81; tertile 3: OR = 4.01, 95% CI: 1.15–13.00).

Discussion

Overall, there is substantial between-study heterogeneity in the direction of observed associations between long-term ozone exposure and asthma development. In addition, available epidemiology studies have considerable methodological limitations, including potential exposure measurement error and a lack of adjustment for several key confounders, which further complicates the interpretation of the findings.

Childhood asthma

The observed associations between ozone exposure and development of childhood asthma varied by exposure window assessed and the age of the study population.

Ozone exposure in utero

Consistent findings from two studies (Clark et al., Citation2010; Sbihi et al., Citation2016) suggested that higher in utero ozone exposure was associated with reduced risk of asthma in preschool-age children. However, the effect estimates for ozone, though statistically significant, were small in magnitude. The observed dose-response relationships appeared to be linear, without any statistical evidence for non-linearity. Notably, in these two studies, ozone exposure was inversely correlated with traffic-related pollutants, a risk factor for childhood asthma. The inverse correlation between ozone and traffic-related pollutants might contribute to, at least partially, the observed inverse association between ozone exposure and asthma in preschool-age children. In addition, the diagnostic accuracy in children aged 6 years or younger (i.e. preschool) is low, and neither of the studies relied on validated ozone exposure estimates or adjusted for key confounders such as a family history of asthma ().

In contrast, Sbihi et al. (Citation2016) reported that higher in utero ozone exposure was linearly associated with a small, but statistically significant, increase in asthma risk among school-age children. The observed association in school-age children was the direct opposite of that in preschool-age children in the same study, which is unlikely to be entirely explained by the better diagnostic accuracy of asthma in school-age children. Moreover, the methodological limitations of this study discussed above also applied to the analyses of school-age children ().

Ozone exposure in the first year of life

Clark et al. (Citation2010) reported decreased risks of asthma development associated with higher ozone exposure in the first year of life, while MacIntyre et al. (Citation2014) observed a null association. The magnitude of the effect estimates, based on a linear dose-response relationship, was small. Both studies suffered from a high risk of bias from the exposure and outcome assessments, as well as from inadequate adjustment for confounders ().

Ozone exposure in early life

The most examined exposure window in available epidemiology studies was early life, but the results from these analyses were inconsistent with regard to the direction of observed associations. Most of the studies assumed a linear dose-response relationship between ozone and asthma development and reported ozone effect estimates that were small in magnitude. The magnitude of the ozone effect estimates observed in Lin et al. (Citation2008) was considerably larger than that in other studies (). As discussed above, Lin et al. (Citation2008) assessed first asthma hospitalization, which indicates severe exacerbation and is a poor surrogate for incident asthma. Because ozone exposure may affect asthma severity (Goodman et al., Citation2018; US EPA, Citation2013a), the use of first asthma hospitalization in Lin et al. (Citation2008) likely biased the results away from the null.

In addition, considerable uncertainty stemmed from the lack of ozone-asthma temporality in most of these studies, with the exception of Nishimura et al. (Citation2013) and Lin et al. (Citation2008). The ozone exposure periods evaluated overlapped with the follow-up periods for asthma; therefore, for most, if not all, of the children who developed asthma, part of their estimated ozone exposures occurred after the outcome occurred. Because of the continuing downward trend of ambient ozone concentration in the USA between 1998 and 2010 (US EPA, Citation2013a), this lack of temporality might have led to an overestimation of the association between early life ozone exposure and asthma development.

Similar to studies that evaluated ozone exposures in utero and in the first year of life, studies of early life ozone exposure were also limited by considerable measurement error and uncertainties in exposure and outcome assessments (). Several studies did not adjust for key confounders, such as a family history of asthma, and most did not control for preterm birth, exposure to traffic-related air pollutants or the indoor environment (). Findings from Asian children populations were less generalizable to the USA than those from the Western populations ().

Because the natural and anthropogenic sources of ozone precursors differ in urban and non-urban areas (US EPA, Citation2013a), it is conceivable that urbanicity could modify potential associations between long-term ambient ozone concentrations and asthma development. However, more than half of the studies of childhood asthma were conducted only in urban areas (Clark et al., Citation2010; Dong et al., Citation2013; Kim et al., Citation2013; Nishimura et al., Citation2013; Sbihi et al., Citation2016; Wang et al., Citation2016), while the rest of the studies included children living in both urban and non-urban areas (Islam et al., Citation2008; Lin et al., Citation2008; MacIntyre et al., Citation2014; McConnell et al., Citation2010; Tetreault et al., Citation2016). There were no apparent patterns in the observed associations between ozone and childhood asthma development with regard to whether the studies were conducted only in urban areas or in urban and non-urban areas combined. Because there were no studies conducted only in non-urban areas, we were unable to examine the association between long-term ozone exposure and childhood asthma development in rural settings.

Adult-onset asthma

Adult-onset asthma was only evaluated in one population, the California Seventh-day Adventists cohort (Abbey et al., Citation1991; Greer et al., Citation1993; McDonnell et al., Citation1999). Long-term ozone exposure was associated with increased asthma risk in men but not women (Greer et al., Citation1993; McDonnell et al., Citation1999). The magnitude of the observed association was large, with the ORs greater than 2. The increased risk in men was persistent when ozone exposure was analyzed linearly, in tertiles, or with exceedance frequencies above various thresholds.

The ozone ISA relied on these studies to conclude that long-term ozone exposure is a risk factor for adult-onset asthma. However, there does not seem to be a biologically plausible reason for the different associations between men and women. Men, on average, had more severe asthma, and thus might have been more likely to get diagnosed with asthma than women in this cohort. Because ozone exposure may be associated with asthma severity, the observed association between ozone and asthma development in men could be partially attributable to the difference in asthma severity (i.e. men appear to have an increased incidence, but it is actually a reflection of men with more severe asthma being diagnosed). Also, in the analyses by Greer et al. (Citation1993) and McDonnell et al. (Citation1999), the exposure periods overlapped with the follow-up periods for asthma (); as discussed above, this might have biased the results away from the null. In addition, these studies did not consider temporal variability when estimating ozone exposure and did not adjust for key confounders, such as a family history of asthma and exposure to other environmental allergens and irritants ().

It is notable that while the Seventh-day Adventists cohort is in California, this population is characterized by markedly lower risks of certain chronic diseases than the US general population, which was hypothesized to be attributable to the lifestyle and diet in the Seventh-day Adventists. The observed association between ozone and asthma in Seventh-day Adventist men, and the effect modification by sex may not be entirely generalizable to the US general population.

Study quality evaluation

A study quality evaluation (i.e. assessing internal validity of individual studies) is a key component in the systematic review process (NRC, Citation2014). There are many study evaluation frameworks available for most realms of evidence, several of which formed the theoretical basis for our study quality criteria (Koustas et al., Citation2013, Citation2014; NTP, Citation2015a,Citationb; US EPA, Citation2013b, Citation2014, Citation2016a,Citationb; von Elm et al., Citation2007a–e;). However, while many of these frameworks provide guidance on key considerations in study quality evaluation, they do not stipulate detailed criteria specific to the exposure and outcome of interest. For example the OHAT RoB approach considers three key domains: exposure characterization, outcome assessment and adjustment for confounding, and several other RoB criteria for observational studies (NTP, Citation2015a,Citationb). Studies with definitely or probably low risk of bias in all three key domains are categorized in the 1st study quality tier and those with definitely or probably high risk of bias in any of the three key domains are categorized in the 2nd or 3rd study quality tiers (NTP, Citation2015a,Citationb). Studies are then evaluated in tiers, but the impact of specific aspects of study quality may not be considered when interpreting study results.

In contrast, our quality criteria address more detailed and distinct characteristics that are specific to long-term ambient ozone exposure and asthma development, resulting in a comprehensive and in-depth assessment of the quality of the overall evidence. We found that all of the available studies had substantial uncertainties in exposure and outcome assessments and in adjustments for confounders, which is consistent with categorizing these studies in 2nd and 3rd tiers using the OHAT approach. The overall low quality of the available studies reduces our confidence in the body of evidence.

Biological plausibility

Some of the reported effects of ozone exposure on the respiratory system are common features of asthma, providing biological plausibility for long-term ozone exposure as a contributor to asthma development. For example when ozone exposure concentrations are high enough and of sufficient duration to overwhelm antioxidant defenses in the respiratory tract, ozone reacts with macromolecules to form secondary oxidation products that can induce respiratory tract inflammation and epithelial cell injury with subsequent airway remodeling (Mudway & Kelly, Citation2000; US EPA, Citation2013a). Inflammation contributes to oxidative stress and reactive oxygen species (ROS) generation, which may cause increased bronchial reactivity (indicating AHR) observed as both an immediate and persistent response to ozone exposure in humans and experimental animals, respectively (US EPA, Citation2013a).

Asthma development also involves alterations in the immune system, and T-cells play a central role in asthma pathogenesis (Wu et al., Citation2014). Development of the allergic asthma phenotype is associated with a skewing of T-cell responses toward a T helper 2 (Th2) immune response instead of a T helper 1 (Th1) response. Th2 responses include several features of asthma, such as increased production of inflammatory cytokines, eosinophils and immunoglobulin E (IgE) antibodies in the respiratory tract, which induces a state of allergic sensitization (Bates et al., Citation2009; Marino et al., Citation2015; Noutsios & Floros, Citation2014). Exposure of children to ozone has been shown to increase eosinophils and proinflammatory cytokines in the respiratory tract (Noutsios & Floros, Citation2014) and short-term ozone exposure studies in rodents and primates have reported enhanced IgE production (US EPA, Citation2013a). Short-term ozone exposure has also been shown to enhance antigen presentation in humans, which contributes to exaggerated T-cell responses and promotes Th2-mediated inflammation and an allergic phenotype (US EPA, Citation2013a). The persistent nature of these short-term responses contributes to the biological plausibility of an association between long-term ozone exposure and development of allergic asthma (US EPA, Citation2013a). We note, however, that although ozone exposure has been linked with Th2-related responses in several studies, there are no direct experimental studies associating ozone exposure with the initial polarization of Th1–Th2 responses (Auten & Foster, Citation2011).

Studies in non-human primates exposed repeatedly to ozone, with or without exposure to house dust mite antigen (an inhaled allergen), provide a model of allergic asthma in humans, as these studies reported reversible impaired airflow, elevated IgE levels in serum and airways, increased eosinophils and other immune cells in the airways and development of AHR (US EPA, Citation2013a). Long-term exposure of infant rhesus monkeys to 0.5 parts per million (ppm) ozone and an antigen-induced greater than additive changes in airway resistance and AHR, and exposure to ozone alone increased eosinophil levels and induced effects related to airway obstruction and AHR, including decreased growth of the distal conducting airways that persisted at least six months after cessation of ozone exposure (Fanucchi et al., Citation2006; Plopper et al., Citation2007; Schelegle et al., Citation2003). This indicates that long-term exposure to ozone and allergens in early life can disrupt growth and differentiation processes in the airways and provides plausibility that ozone could contribute to asthma development in children.

Several genetic factors that confer susceptibility to asthma development have been identified (Gowers et al., Citation2012; US EPA, Citation2013a). Some of these factors may modify asthma risk by affecting the internal dose of ozone reaction products or their response in the respiratory tract, providing biological plausibility for ozone exposure having a role in asthma development. For example variation in genes for antioxidant or anti-inflammatory enzymes could increase susceptibility to ozone-induced oxidative stress, inflammation and subsequent airway remodeling (Gowers et al., Citation2012). Another hypothesis is that in those with a genetic predisposition to atopy (i.e. a tendency to develop allergic diseases, such as asthma), there is a dominant Th2 inflammatory phenotype, and continuous exposure to ozone and allergens could cause atopic bronchial hyperresponsiveness and lead to asthma (Gowers et al., Citation2012; Marino et al., Citation2015).

Variability of asthma phenotypes has also been hypothesized to be attributable to epigenetic influences from early life environmental exposures (such as to ozone). In in vitro studies, histone modification and DNA methylation of Th lymphocyte genes have been induced by perinatal exposure to environmental insults, such as oxidative stress, leading to polarization toward Th2 responses associated with development of allergic asthma (Noutsios & Floros, Citation2014). Thus, it is plausible that ozone exposure may induce epigenetic changes associated with development of certain asthma phenotypes, although there are no studies available to support this directly.

Overall, the experimental evidence discussed above indicates that ozone exposure can induce many persistent respiratory effects that are also involved in asthma pathogenesis, suggesting that long-term ozone exposure could plausibly contribute to asthma development. However, the underlying mechanisms of asthma development in humans are poorly understood, so it is unclear whether the ozone-induced effects are direct contributors to asthma onset.

Conclusion

Available epidemiology studies of long-term ozone exposure, including in utero exposure, and development of childhood asthma reported inconsistent findings, which were further weakened by considerable methodological limitations in exposure and outcome assessments, and in statistical analyses. Epidemiology findings regarding long-term ozone exposure and adult-onset asthma, from one unique population with limited generalizability to the general population, were also limited by considerable uncertainties due to exposure measurement error and a lack of adjustment for key confounders. While experimental evidence suggests that it may be biologically plausible that long-term ozone exposure could contribute to asthma development, it has not established a definitive mode of action. Future research is needed to address key uncertainties regarding the role of ambient ozone exposure in asthma development.

Acknowledgments

The authors gratefully acknowledge the editorial review provided by Ms. Carla Walker (Gradient).

Disclosure statement

The authors are employed by Gradient, a private environmental consulting firm.

Additional information

Funding

The work reported in this article was conducted by the authors during the normal course of employment with financial support provided to Gradient by the Electric Power Research Institute (EPRI). This article was reviewed by members of EPRI while in preparation, but the authors retain sole responsibility for the writing, content and conclusions in this article.

References

  • Abbey DE, Mills PK, Petersen FF, Beeson WL. (1991). Long-term ambient concentrations of total suspended particulates and oxidants as related to incidence of chronic disease in California Seventh-day Adventists. Environ Health Perspect 94:43–8.
  • Akinbami LJ, Moorman JE, Bailey C, et al. (2012). Trends in asthma prevalence, health care use, and mortality in the United States, 2001–2010. NCHS Data Brief 94:1–8.
  • American Thoracic Society, Ad Hoc Committee on Issues in Screening for Asthma in Children (ATS). (2007). An official ATS workshop report: issues in screening for asthma in children. Proc Am Thorac Soc 4:133–41.
  • Auten RL, Foster WM. (2011). Biochemical effects of ozone on asthma during postnatal development. Biochim Biophys Acta 1810:1114–9.
  • Bates JH, Rincon M, Irvin CG. (2009). Animal models of asthma. Am J Physiol Lung Cell Mol Physiol 297:L401–10.
  • Clark NA, Demers PA, Karr CJ, et al. (2010). Effect of early life exposure to air pollution on development of childhood asthma. Environ Health Perspect 118:284–90.
  • Currie GP, Baker JFW. (eds.). (2012). Asthma. 2nd ed. Oxford, UK: Oxford University Press.
  • Dong GH, Qian Z, Liu MM, et al. (2013). Obesity enhanced respiratory health effects of ambient air pollution in Chinese children: the seven northeastern cities study. Int J Obes 37:94–100.
  • Fanucchi MV, Plopper CG, Evans MJ, et al. (2006). Cyclic exposure to ozone alters distal airway development in infant rhesus monkeys. Am J Physiol Lung Cell Mol Physiol 291:L644–50.
  • Global Initiative for Asthma (GINA). (2017). Global strategy for asthma management and prevention. Available from: http://ginasthma.org/download/317/.
  • Goodman JE, Zu K, Loftus CT, et al. (2018). Short-term ozone exposure and asthma severity: weight-of-evidence analysis. Environ Res 160:391–7.
  • Gowers AM, Cullinan P, Ayres JG, et al. (2012). Does outdoor air pollution induce new cases of asthma? biological plausibility and evidence; a review. Respirology 17:887–98.
  • Grainge CL, Davies DE. (2013). Epithelial injury and repair in airways diseases. Chest 144:1906–12.
  • Greer JR, Abbey DE, Burchette RJ. (1993). Asthma related to occupational and ambient air pollutants in nonsmokers. J Occup Med 35:909–15.
  • Ilmarinen P, Tuomisto LE, Kankaanranta H. (2015). Phenotypes, risk factors, and mechanisms of adult-onset asthma. Mediators Inflamm 2015:514868.
  • Islam T, McConnell R, Gauderman WJ, et al. (2008). Ozone, oxidant defense genes, and risk of asthma during adolescence. Am J Respir Crit Care Med 177:388–95.
  • Kim BJ, Seo JH, Jung YH, et al. (2013). Air pollution interacts with past episodes of bronchiolitis in the development of asthma. Allergy 68:517–23.
  • Koustas E, Lam J, Sutton P, et al. (2013). Applying the Navigation Guide: Case Study #1 – The impact of developmental exposure to perfluorooctanoic acid (PFOA) on fetal growth, a systematic review of the non-human evidence (final protocol). Available from: http://coe.ucsf.edu/prhe/pdfs/PFOA%20NON-HUMAN%20PROTOCOL.pdf.
  • Koustas E, Lam J, Sutton P, et al. (2014). The Navigation Guide – evidence-based medicine meets environmental health: systematic review of nonhuman evidence for PFOA effects on fetal growth. Environ Health Perspect 122:1015–27.
  • Lin S, Liu X, Le LH, Hwang SA. (2008). Chronic exposure to ambient ozone and asthma hospital admissions among children. Environ Health Perspect 116:1725–30.
  • MacIntyre EA, Bauer M, Melen E, et al. (2014). GSTP1 and TNF Gene variants and associations between air pollution and incident childhood asthma: the traffic, asthma and genetics (TAG) study. Environ Health Perspect 122:418–24.
  • Marino E, Caruso M, Campagna D, Polosa R. (2015). Impact of air quality on lung health: myth or reality? Ther Adv Chronic Dis 6:286–98.
  • McConnell R, Islam T, Shankardass K, et al. (2010). Childhood incident asthma and traffic-related air pollution at home and school. Environ Health Perspect 118:1021–6.
  • McDonnell WF, Abbey DE, Nishino N, Lebowitz MD. (1999). Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: the Ahsmog study. Environ Res 80:110–21.
  • Moorman JE, Akinbami LJ, Bailey CM, et al. (2012). National surveillance of asthma: United States, 2001–2010. Vital Health Stat 3:1–67.
  • Mudway IS, Kelly FJ. (2000). Ozone and the lung: a sensitive issue. Mol Aspects Med 21:1–48.
  • Myers TR, Tomasio L. (2011). Asthma: 2015 and beyond. Respir Care 56:1389–407.
  • National Toxicology Program (NTP). (2015a). Handbook for conducting a literature-based health assessment using OHAT approach for systematic review and evidence integration. Office of Health Assessment and Translation (OHAT). Available from: http://ntp.niehs.nih.gov/pubhealth/hat/noms/index-2.html.
  • National Toxicology Program (NTP). (2015b). OHAT risk of bias rating tool for human and animal studies. Office of Health Assessment and Translation (OHAT). Available from: http://ntp.niehs.nih.gov/pubhealth/hat/noms/index-2.html.
  • Nishimura KK, Galanter JM, Roth LA, et al. (2013). Early-life air pollution and asthma risk in minority children. The GALA II and SAGE II studies. Am J Respir Crit Care Med 188:309–18.
  • Noutsios GT, Floros J. (2014). Childhood asthma: causes, risks, and protective factors; a role of innate immunity. Swiss Med Wkly 144:
  • National Research Council (NRC). (2014). Review of EPA’s Integrated Risk Information System (IRIS) process. Washington, DC: National Academies Press. Available from: http://www.nap.edu/catalog.php?record_id=18764. [Last accessed: 6 May 2014].
  • Plopper CG, Smiley-Jewell SM, Miller LA, et al. (2007). Asthma/allergic airways disease: does postnatal exposure to environmental toxicants promote airway pathobiology? Toxicol Pathol 35:97–110.
  • Sbihi H, Tamburic L, Koehoorn M, Brauer M. (2016). Perinatal air pollution exposure and development of asthma from birth to age 10 years. Eur Respir J 47:1062–71.
  • Schelegle ES, Miller LA, Gershwin LJ, et al. (2003). Repeated episodes of ozone inhalation amplifies the effects of allergen sensitization and inhalation on airway immune and structural development in Rhesus monkeys. Toxicol Appl Pharmacol 191:74–85.
  • Shin YS, Takeda K, Gelfand EW. (2009). Understanding asthma using animal models. Allergy Asthma Immunol Res 1:10–8.
  • Subbarao P, Mandhane PJ, Sears MR. (2009). Asthma: epidemiology, etiology and risk factors. CMAJ 181:E181–90.
  • Tetreault LF, Doucet M, Gamache P, et al. (2016). Childhood exposure to ambient air pollutants and the onset of asthma: an administrative cohort study in Québec. Environ Health Perspect 124:1276–82.
  • United States Environmental Protection Agency (US EPA). (2013a). Integrated science assessment for ozone and related photochemical oxidants (final). National Center for Environmental Assessment (NCEA). Washington, DC: US EPA, EPA/600/R–10/076F.
  • United States Environmental Protection Agency (US EPA). (2013b). Materials submitted to the national research council part I: Status of implementation of recommendations. Integrated Risk Information System Program. Washington, DC: US EPA.
  • United States Environmental Protection Agency (US EPA). (2014). Draft Development Materials for the Integrated Risk Information System (IRIS) Toxicological Review of Inorganic Arsenic [CASRN 7440-38-2], EPA/630/R-14/101. Washington, DC: US EPA.
  • United States Environmental Protection Agency (US EPA). (2016a). Integrated science assessment for oxides of nitrogen – Health criteria (final). National Center for Environmental Assessment (NCEA), EPA/600/R-15/068. Washington, DC: US EPA.
  • United States Environmental Protection Agency (US EPA). (2016b). Integrated science assessment for sulfur oxides - Health criteria (second external review draft). National Center for Environmental Assessment (NCEA), EPA/600/R-16/351. Washington, DC: US EPA.
  • von Elm E, Altman DG, Egger M, et al. (2007a). Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–8.
  • von Elm E, Altman DG, Egger M, et al. (2007b). STROBE statement - checklist of items that should be included in reports of case-control studies. Available from: https://www.strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_case-control.pdf.
  • von Elm E, Altman DG, Egger M, et al. (2007c). STROBE statement - items to be included when reporting observational studies in a conference abstract. Available from: https://strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_conference_abstract_DRAFT.pdf.
  • von Elm E, Altman DG, Egger M, et al. (2007d). STROBE statement - checklist of items that should be included in reports of cross-sectional studies. Available from: https://strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_cross-sectional.pdf.
  • von Elm E, Altman DG, Egger M, et al. (2007e). STROBE statement - checklist of items that should be included in reports of observational studies. Available from: https://strobe-statement.org/fileadmin/Strobe/uploads/checklists/STROBE_checklist_v4_combined_PlosMedicine.pdf.
  • Wang IJ, Tung TH, Tang CS, Zhao ZH. (2016). Allergens, air pollutants, and childhood allergic diseases. Int J Hyg Environ Health 219:66–71.
  • Wu D, Tan W, Zhang Q, et al. (2014). Effects of ozone exposure mediated by BEAS-2B cells on T cells activation: a possible link between environment and asthma. Asian Pac J Allergy Immunol 32:25–33.